This drug is contraindicated in the following patients: Patients with hemorrhage (e.g., hemophilia, increased capillary, agility, intracranial hemorrhage, upper gastrointestinal hemorrhage, hemorrhage in the urinary tract, hemoptysis, and hemorrhage in the vitreous body) and with any known predisposition to bleeding (e.g. active peptic ulceration, recent (within six months) haemorrhagic stroke, surgery within the previous three months, proliferative diabetic retinopathy, poorly controlled hypertension) (bleeding tendency may be increased).
Patients with congestive heart failure. (Symptoms may be exacerbated.)
Patients with a history of hypersensitivity to any ingredient of the drug.
Women who are pregnant or may possibly become pregnant or are nursing mothers (see 'Use in Pregnancy & Lactation').